Cargando…

A molecular signature in blood identifies early Parkinson’s disease

BACKGROUND: The search for biomarkers in Parkinson’s disease (PD) is crucial to identify the disease early and monitor the effectiveness of neuroprotective therapies. We aim to assess whether a gene signature could be detected in blood from early/mild PD patients that could support the diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molochnikov, Leonid, Rabey, Jose M, Dobronevsky, Evgenya, Bonuccelli, Ubaldo, Ceravolo, Roberto, Frosini, Daniela, Grünblatt, Edna, Riederer, Peter, Jacob, Christian, Aharon-Peretz, Judith, Bashenko, Yulia, Youdim, Moussa BH, Mandel, Silvia A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424147/ https://www.ncbi.nlm.nih.gov/pubmed/22651796 http://dx.doi.org/10.1186/1750-1326-7-26

Ejemplares similares

Negative DAT‐SPECT in Old Onset Parkinson's Disease: An Additional Pitfall?
por: Palermo, Giovanni, et al.
Publicado: (2022)

Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
por: Youdim, Moussa B.H.
Publicado: (2013)

The Epidemiology and Clinical Manifestations of Dysexecutive Syndrome in Parkinson’s Disease
por: Ceravolo, Roberto, et al.
Publicado: (2012)

Non-pharmacological interventions for Parkinson's disease mild cognitive impairment: future directions for research
por: Cammisuli, Davide Maria, et al.
Publicado: (2020)

Freezing of gait and dementia in parkinsonism: A retrospective case–control study
por: Palermo, Giovanni, et al.
Publicado: (2019)

Promise of Neurorestoration and Mitochondrial Biogenesis in Parkinson's Disease with Multi Target Drugs: An Alternative to Stem Cell Therapy
por: Youdim, Moussa BH, et al.
Publicado: (2013)

Quantitative susceptibility mapping in atypical Parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2019)

Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay
por: Cammisuli, Davide Maria, et al.
Publicado: (2021)

Transcranial Direct Current Stimulation (tDCS) as a Useful Rehabilitation Strategy to Improve Cognition in Patients With Alzheimer's Disease and Parkinson's Disease: An Updated Systematic Review of Randomized Controlled Trials
por: Cammisuli, Davide Maria, et al.
Publicado: (2022)

Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson’s Disease
por: Elefante, Camilla, et al.
Publicado: (2021)

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
por: Riederer, Peter, et al.
Publicado: (2023)

Therapeutic potential of a novel multifunctional iron chelator on cognitive decicits and insulin degrading enzyme expression in a rat model of sporadic Alzheimer's disease
por: Knezović, Ana, et al.
Publicado: (2012)

Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study
por: Durrenberger, Pascal. F., et al.
Publicado: (2012)

Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies
por: Palermo, Giovanni, et al.
Publicado: (2020)

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?
por: Youdim, Moussa B. H.
Publicado: (2010)

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
por: Daniele, Simona, et al.
Publicado: (2018)

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents
por: Youdim, Moussa B. H.
Publicado: (2010)

The neurobiological link between OCD and ADHD
por: Brem, Silvia, et al.
Publicado: (2014)

Correction: Methylphenidate enhances neural stem cell differentiation
por: Bartl, Jasmin, et al.
Publicado: (2013)

Methylphenidate enhances neural stem cell differentiation
por: Bartl, Jasmin, et al.
Publicado: (2013)

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
por: Cilia, Roberto, et al.
Publicado: (2011)

Selegiline: a molecule with innovative potential
por: Tábi, Tamás, et al.
Publicado: (2019)

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
por: Nagatsu, Toshiharu, et al.
Publicado: (2023)

Virtual Reality Feedback Cues for Improvement of Gait in Patients with Parkinson's Disease
por: Badarny, Samih, et al.
Publicado: (2014)

Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome
por: Unti, Elisa, et al.
Publicado: (2019)

Physiological and pathological aspects of Aβ in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators
por: Avramovich-Tirosh, Yael, et al.
Publicado: (2008)

Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region
por: Del Prete, Eleonora, et al.
Publicado: (2020)

Risk factors for impulse control disorders and related behaviors in Parkinson’s disease: secondary analyses of the ICARUS study
por: Barone, Paolo, et al.
Publicado: (2019)

Aerobic Exercise and Healthy Nutrition as Neuroprotective Agents for Brain Health in Patients with Parkinson’s Disease: A Critical Review of the Literature
por: Cammisuli, Davide Maria, et al.
Publicado: (2020)

From Narcissistic Personality Disorder to Frontotemporal Dementia: A Case Report
por: Poletti, Michele, et al.
Publicado: (2011)

Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction
por: Grünblatt, Edna, et al.
Publicado: (2015)

Hemispheric differences in the mesostriatal dopaminergic system
por: Molochnikov, Ilana, et al.
Publicado: (2014)

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
por: Antonini, Angelo, et al.
Publicado: (2008)

New Approaches to Treating Alzheimer’s Disease
por: Zheng, Hailin, et al.
Publicado: (2015)

From Single Target to Multitarget/Network Therapeutics in Alzheimer’s Therapy
por: Zheng, Hailin, et al.
Publicado: (2014)

The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging
por: Kupershmidt, Lana, et al.
Publicado: (2023)

Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application
por: Benkler, Chen, et al.
Publicado: (2010)

Methylphenidate enhances neuronal differentiation and reduces proliferation concomitant to activation of Wnt signal transduction pathways
por: Grünblatt, Edna, et al.
Publicado: (2018)

Editorial: Obsessive-compulsive related disorders (OCRD) across the lifespan
por: Lochner, Christine, et al.
Publicado: (2023)

Is there a subtype of developmental Parkinson's disease?
por: Riederer, P.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_s9dcd4bfbbok64dkqc3jfcrv65